Fulgent Genetics(FLGT) - 2025 Q4 - Earnings Call Transcript

Fulgent Genetics (NasdaqGM:FLGT) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAndrew Cooper - Director and Equity ResearchBrandon Perthuis - Chief Commercial OfficerDavid Westenberg - Managing Director and Equity ResearchLauren Sloane - Head of Investor RelationsLu Li - Healthcare Equity Research and DirectorMing Hsieh - Chairman and CEOPaul Kim - CFOOperatorGreetings, welcome to Fulgent Genetics Fourth Quarter 2025 Conference Call and Webcast. At this time, all participants are i ...